Nicolas Çuburu[Author] - Search Results

Year	Number of Results
2004	2
2007	1
2008	1
2009	2
2010	2
2011	4
2012	3
2013	2
2014	2
2015	4
2016	2
2017	1
2018	3
2019	1
2022	3
2024	1

1

Czerkinsky C, Cuburu N, Kweon MN, Anjuere F, Holmgren J. Czerkinsky C, et al. Among authors: cuburu n. Hum Vaccin. 2011 Jan 1;7(1):110-4. doi: 10.4161/hv.7.1.13739. Epub 2011 Jan 1. Hum Vaccin. 2011. PMID: 21263223 Review.

2

Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors.

Çuburu N, Bialkowski L, Pontejo SM, Sethi SK, Bell ATF, Kim R, Thompson CD, Lowy DR, Schiller JT. Çuburu N, et al. Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2116738119. doi: 10.1073/pnas.2116738119. Epub 2022 Jun 24. Proc Natl Acad Sci U S A. 2022. PMID: 35749366 Free PMC article.

3

Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines.

Çuburu N, Finn OJ, Van Der Burg SH. Çuburu N, et al. Front Immunol. 2022 May 24;13:924099. doi: 10.3389/fimmu.2022.924099. eCollection 2022. Front Immunol. 2022. PMID: 35686125 Free PMC article. No abstract available.

4

Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity.

Mazor R, King EM, Onda M, Cuburu N, Addissie S, Crown D, Liu XF, Kishimoto TK, Pastan I. Mazor R, et al. Among authors: cuburu n. Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E733-E742. doi: 10.1073/pnas.1717063115. Epub 2018 Jan 8. Proc Natl Acad Sci U S A. 2018. PMID: 29311317 Free PMC article. Review.

5

Genital delivery of virus-like particle and pseudovirus-based vaccines.

Cuburu N, Chackerian B. Cuburu N, et al. Expert Rev Vaccines. 2011 Sep;10(9):1245-8. doi: 10.1586/erv.11.104. Expert Rev Vaccines. 2011. PMID: 21919611 Free PMC article.

6

Epigenetic repression of antiviral genes by SARS-CoV-2 NSP1.

Anastasakis DG, Benhalevy D, Çuburu N, Altan-Bonnet N, Hafner M. Anastasakis DG, et al. Among authors: cuburu n. PLoS One. 2024 Jan 26;19(1):e0297262. doi: 10.1371/journal.pone.0297262. eCollection 2024. PLoS One. 2024. PMID: 38277395 Free PMC article.

7

Mouse model of cervicovaginal papillomavirus infection.

Çuburu N, Cerio RJ, Thompson CD, Day PM. Çuburu N, et al. Methods Mol Biol. 2015;1249:365-79. doi: 10.1007/978-1-4939-2013-6_27. Methods Mol Biol. 2015. PMID: 25348320

8

Moving forward with human papillomavirus immunotherapies.

Çuburu N, Schiller JT. Çuburu N, et al. Hum Vaccin Immunother. 2016 Nov;12(11):2875-2880. doi: 10.1080/21645515.2016.1199302. Epub 2016 Jul 7. Hum Vaccin Immunother. 2016. PMID: 27388123 Free PMC article.

9

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial.

Tsang SH, Schiller JT, Porras C, Kemp TJ, Herrero R, Schussler J, Sierra MS, Cortes B, Hildesheim A, Lowy DR, Rodríguez AC, Romero B, Çuburu N, Shing JZ, Pinto LA, Sampson JN, Kreimer AR; Costa Rica HPV Vaccine Trial Group. Tsang SH, et al. Among authors: cuburu n. NPJ Vaccines. 2022 Mar 29;7(1):40. doi: 10.1038/s41541-022-00431-x. NPJ Vaccines. 2022. PMID: 35351898 Free PMC article.

10

A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8⁺ Memory T Cells.

Çuburu N, Kim R, Guittard GC, Thompson CD, Day PM, Hamm DE, Pang YS, Graham BS, Lowy DR, Schiller JT. Çuburu N, et al. J Immunol. 2019 Feb 15;202(4):1250-1264. doi: 10.4049/jimmunol.1800219. Epub 2019 Jan 11. J Immunol. 2019. PMID: 30635393 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

30 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year